반응식
[N:1]1[CH:6]=[CH:5][C:4]([C:7]2[NH:11][C:10]3[CH:12]=[CH:13][CH:14]=[C:15]([C:16]([OH:18])=O)[C:9]=3[N:8]=2)=[CH:3][CH:2]=1.[B-](F)(F)(F)F.CCO[C:27]([C:29]([C:39]#[N:40])=NOC(N(C)C)=[N+](C)C)=O.[CH:41](N(C(C)C)CC)(C)C.C[N:51]([CH:53]=[O:54])C>>[N:1]1[CH:2]=[CH:3][C:4]([C:7]2[NH:11][C:10]3[CH:12]=[CH:13][CH:14]=[C:15]([C:16]([NH:40][C@H:39]([C:53]([NH2:51])=[O:54])[CH:29]([CH3:41])[CH3:27])=[O:18])[C:9]=3[N:8]=2)=[CH:5][CH:6]=1참가 물질
5
실험 절차
120 mg (0.5 mmol) of 2-(pyrid-4-yl)-1H-benzimidazole-4-carboxylic acid (1d) and 76.4 mg (0.5 mmol) of H-(L)-valinamide were dissolved in 5 ml of DMF. 164 mg (0.5 mmol) of TOTU and 0.086 ml of diisopropylethylamine were added and the mixture was stirred at RT for 3 h. The precipitate was filtered off and the filtrate was concentrated. The residue was dissolved in ethyl acetate, the solution was washed with saturated sodium chloride solution, and the organic phase was dried using anhydride sodium sulfate and concentrated. Yield: 168 mg (99%). (M+H)+=338.2 (Cl+).
후처리
- filtrationThe precipitate was filtered off
- concentrationthe filtrate was concentrated
- dissolutionThe residue was dissolved in ethyl acetate
- washthe solution was washed with saturated sodium chloride solution
- customthe organic phase was dried
- concentrationconcentrated
출처 및 근거
- ORD 기록
- ord-cc209c226de84ecb942c3b52c5f48169
- 출처 데이터셋
- uspto-grants-2002_03
- 특허 번호
- US06358978B1
연결된 노트
불러오는 중…